Vitamin D (25-OH) in Long COVID

Vitamin D (25-OH), also described as Calcidiol, is a metabolic marker with mixed findings in Long COVID (PASC, Post-Acute Sequelae of COVID-19): studies comparing patients with healthy controls report both increases and decreases. The cited literature links this alteration to immune modulation. The finding is drawn from Kallaste et al. 2025; it describes group-level differences, not a threshold that classifies an individual.

↕ InconsistentMetabolicLOINC 1989-3

Summary

Direction in Long COVID↕ Inconsistent — reported as both higher and lower across studies, with no consistent direction
CategoryMetabolic
Also described asCalcidiol
Compared againstHC (healthy controls)
Associated symptomsImmune modulation
Test typeBlood test (serum / plasma / whole blood)
LOINC code1989-3
SourceKallaste et al. 2025 — doi:10.3390/medicina61060996
Condition atlasLong COVID Biomarker Atlas

Other conditions where Vitamin D (25-OH) is reported

See the cross-condition hub: Vitamin D (25-OH) across conditions.

Trials, interventions and tests

In clinical-trial registrations this marker maps to the outcome term Levels of vitamin D (5 registered trials use a matching outcome measure).

Clinical trials using Vitamin D (25-OH) as an outcome

Interventions studied alongside this marker

Hypothesis-generating links from trial outcome usage and literature co-occurrence. Not treatment recommendations.

Commercial test availability

Vitamin D, 25-Hydroxy — commercial laboratory test.

Links are for reference only; availability, specimen requirements and coverage vary by location.

Also sold as a nutrient or supplement

Vitamin D3 (cholecalciferol) (vitamin). 25-OH vitamin D is the measured metabolite; D3 is the common supplement form. This tag means the analyte is also available orally; it is not a product endorsement and a low or high level does not by itself justify supplementation.

Related Metabolic markers in Long COVID

Full list: Long COVID Biomarker Atlas.

Frequently asked questions

Is Vitamin D (25-OH) high or low in Long COVID?

Mixed. Some studies report higher and others lower Vitamin D (25-OH) in Long COVID compared with healthy controls, so no single direction is established. Source: Kallaste et al. 2025.

What symptoms is Vitamin D (25-OH) associated with in Long COVID?

The cited literature associates this marker with Immune modulation. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures Vitamin D (25-OH)?

It is measured as a blood test (serum / plasma / whole blood). The standard laboratory code is LOINC 1989-3. Commercial laboratories such as Quest Diagnostics, LabCorp, Ulta Lab Tests list an orderable assay.

Is one abnormal Vitamin D (25-OH) result diagnostic of Long COVID?

No. No single biomarker is diagnostic of Long COVID. Vitamin D (25-OH) findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is Vitamin D (25-OH) specific to Long COVID?

No. The same marker is also reported in Gulf War Illness in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). Vitamin D (25-OH) in Long COVID: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/long-covid/vitamin-d-25-oh.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Page generated from long-covid.json · Browse: Long COVID atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.